CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG...

69
CLAUDIO MAFFEIS Pediatria Indirizzo Diabetologico e Malattie del Metabolismo Università Verona L’obesità non è tutta nei geni

Transcript of CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG...

Page 1: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

CLAUDIO MAFFEISPediatria Indirizzo Diabetologico e Malattie del Metabolismo

Università Verona

L’obesità non è tutta nei geni

Page 2: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic
Page 3: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic
Page 4: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic
Page 5: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Indagine Okkio alla SalutePrevalenza obesità bambini 8-9 anni

Page 6: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Maffeis C et al. J Clin Endocrinol Metab 2002;87:71-76

50

0

normal

weight

total

sample

(%)

measured

in

adulthood

over

weightobese

25

relative BMI at baseline (%)

adult BMI(reciprocal)

100

r = -0.52, P<0.01

0.06

0.04

0.02

135 170 205 240

persistence of obesity from childhood into adulthood

Page 7: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood

Twig G, et al. NEJM 2016

Page 8: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

80

60

40

20

0

lost offollow-up

SDS BMIreduction<0.5

SDS BMIreduction>0.5

Reinehr T, et al Obesity 2009

time (months)

6 12 24 6 12 24 6 12 24

80

60

40

20

0

(%)

lost offollow-up

SDS BMIreduction<0.5

SDS BMIreduction>0.5

time (months)

6 12 24 6 12 24 6 12 24

129 treatment centers 5 centers with the highest success rate

(%)

Two-year Follow-up in 21,784 Overweight Childrenand Adolescents With Lifestyle Intervention

100100

Page 9: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic
Page 10: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Consensus Conference su Diagnosi, Trattamento e Prevenzione dell’Obesità del Bambino e dell’Adolescente

• Diagnosi

• Comorbilità

• Terapia

• Prevenzione

Page 11: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic
Page 12: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Maffeis C, et al. J Pediatr 2008

Metabolic syndromeRisk to develop

metabolic syndrome

Independent variables No Yes OR (95% CI)

Normal weight with W/Hr <0.5 938 22 1

Normal weight with W/Hr >0.5 13 1 4.01 (0.49-32.97)

Over weight with W/Hr <0.5 132 10 3.34 (1.52-7.37) *

Over weight with W/Hr >0.5 72 16 8.16 (3.87-17.23) **

Obese with W/Hr >0.5 208 67 12.11 (7.08-20.71) **

W/Hr = waist/height ratio * P < .05. ** P < .001.

WH

Odds ratio to have the metabolic syndrome in subjects with a W/Hr

>0.5 within normal-weight, overweight, and obese BMI categories

Childhood Obesity Group of the Italian Society of Pediatric Endocrinology & Diabetology

Page 13: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Indicazioni operative

Misurate peso e statura e calcolare BMI

Confrontare il BMI con le tabelle di riferimento del BMI (WHO)

per diagnosi di:

- Sottopeso

- Sovrappeso

- Obesità

Misurare la circonferenza della vita e calcolare il rapporto

circonferenza/statura.

Se il rapporto è > 0,5 = rischio metabolico

Page 14: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Consensus Conference su Diagnosi, Trattamento e Prevenzione dell’Obesità del Bambino e dell’Adolescente

• Diagnosi

• Comorbilità

• Terapia

• Prevenzione

Page 15: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic
Page 16: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Tirosh A, et al. NEJM 2011;364:1315-25

Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease

Page 17: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012

Davis EM, et al. N Engl J Med. 2017 April 13; 376(15): 1419–1429

Page 18: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Impact of Severe Obesity on Cardiovascular Risk Factors in Youth

Predictors of the presence of CVRFC on follow-up

Zabarsky G, et al. J Pediatr 2018; 192:105-14

Page 19: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Magnussen CG, et al. Circulation 2010;122:1604-11.

Youth Overweight and Metabolic Disturbances in Predicting CarotidIntima-Media Thickness, Type 2 Diabetes, and Metabolic Syndrome in Adulthood:

The Cardiovascular Risk in Young Finns Study

Gr. I: NW, no metab. dist.;

Gr II: NW, 1+ metab. dist.;

Gr. III: OW/Ob, no metab. dist.;

Gr. IV: OW/Ob, 1+ metab. dist.

Page 20: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

BMI increase through puberty and adolescence is associated with risk of adult stroke

Gothenburg, Sweden

37,669 men born in 1945–61

BMI at age 8

BMI change through

puberty and adolescence

(BMI at age 20–BMI at age 8)

End follow-up December 2013

Ohlsson C, et al. Neurology 2017;89:363-7.

Page 21: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Change in Overweight from Childhood toEarly Adulthood and Risk of Type 2 Diabetes

Bjerregaard LG, et al. N Engl J Med 2018;378:1302-12

Page 22: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Fasting Plasma Glucose Levels Within the Normoglycemic Range In Childhood as a Predictor of Prediabetes and Type 2 Diabetes in Adulthood

The Bogalusa Heart Study

Nguyen QM, et al. 2010:164:124-8.

Morandi A, et al. Pediatr Obes. 2014;9:17-25

Maffeis C, et al. Obesity. 2010;18:1437-42

Di Bonito P, et al. Obesity. 2014;22(8):1860-4.

Page 23: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

TG predicts

CVD

Page 24: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

The hyperbolic curves for NGT, IGM, and diabetes, assuming a slope of 1, are plotted for I0–30/G0–30 versus 1/fasting insulin.

Utzschneider KM et al Diab Care 32:335–341, 2009

Page 25: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth

Kim JY, et al. Diabetes Care 2016;39:1431–1439

Page 26: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Olivieri F, …Maffeis C. Int J Obes 2018 (in press)

“IGT 1 -like” status in normoglucose tolerant obese children and adolescents: the additive role of glucose profile morphology and 2-hours glucose concentrationduring the oral glucose tolerance test

Page 27: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Indicazioni operative

Esami biochimici a digiuno

Glicemia > 100 mg/dL = alterata glicemia; > 125 mg/dL = diabete

Se 86-100 mg/dL predittore di diabete tipo 2 nel lungo termine

Trigliceridi > 100 mg/dL se <10 aa, poi > 130 mg/dL

HDL colestrolo < 40 mg/dL

LDL colesterolo > 130 mg/dL

Pressione arteriosa

>90° percentile (per sesso, età e altezza) = elevata

95° percentile (per sesso, età e altezza) = ipertensione

Steatosi epatica

Ecografia addome superiore

Page 28: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Consensus Conference su Diagnosi, Trattamento e Prevenzione dell’Obesità del Bambino e dell’Adolescente

• Diagnosi

• Comorbilità

• Terapia

• Prevenzione

Page 29: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

NUTRIENTBALANCE

BODY COMPOSITION

BEHAVIOUR

GENE

ENVIRONMENT

NEUROENDOCRINE SYSTEM

Maffeis C, 2006

Page 30: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Loci associated with BMI, body fat percentage , waist-hip-ratio adjusted for BMI, VAT, SAT, and their ratio (VAT/SAT), and extremes of body mass index and waist-hip-ratio. *

*Genes implicated in monogenic obesity are underlined. Fall T, et al. Gastroenterology. 2017; 152: 1695–1706

Page 31: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Fall T, et al. Gastroenterology. 2017; 152: 1695–1706

Page 32: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

the pathways by which gut hormones regulate energy homeostasis

Murphy KG & Bloom SR Nature 2006

Page 33: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Childhood and Adolescence Obesity:Principles of Treatment

Diet

Exercise

Motivation

Adherence

Efficacy

Maintenance

Open questions:

Main

Target

Change of

behavior

drugs (?) surgery (?)

Page 34: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Primary Prevention of Cardiovascular Disease with a Mediterranean DietSupplemented with Extra-Virgin Olive Oil or Nuts

Acute myocardial infarction, stroke, or death from cardiovascular causes

Estruch R, et al. NEJM 2018;378:e34.

Page 35: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

= increases the risk of MetS; = decreases the risk of MetS; ? = uncertain relation to MetS

Foods related to the metabolic syndrome in two plant-based diets

Sabaté J & Wien M. Br J Nutr 2015;113:S136-S143

Page 36: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Multivariable Ors for significant youth predictors of adult MetS

Childhood Nutrition in Predicting Metabolic Syndrome in AdultsThe Cardiovascular Risk in Young Finns Study

Jaaskelainen P, et al. Diab Care 2012;35:1937-43.

Page 37: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Microbiota-accessible carbohydrate fermentors produce SCFAsthat can have multiple interactions with host tissues.

Gentile CL, Weir TL. Science 2018;362:776-80

Page 38: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Association of dietary intake with prospective changes in cardiometabolicoutcome among students participating in the Healthy Hearts Study.

Dietary intake and prospective changes in

cardiometabolic risk factors in children and youth

Setayeshgar S, et al. Appl. Physiol. Nutr. Metab. 2017;42:39–45

Page 39: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

50

25

0

fatmass(%)

10 30 50

lipid intake (% of energy intake)

Maffeis C et al. Int J Obes ‘96

r = 0.28 P< 0.01

Gazzaniga JM, et al.AJCN ‘93

Klesges RC et al. AJCN ‘94

fatty foodmore palatable

high energy density

less satiating

Page 40: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

60

70

80

90

100

110

120

130

140

0' 60' 90' 120' 150' 180' 240' 300'

LF meal

HF meal

Time (min)

TAG(mg/dl)

p< 0.05

Postprandial triacylglycerol profile after two isocaloric, isoproteicmeals with different fat and carboidrate content in obese children

Maffeis C, et al. Obesity 2010

0 100 200 300

140

120

100

80

60

Fat/Carbohydrate

Fat/Carbohydrate

Page 41: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

65

75

85

95

(U/l)P<0.05

P = ns

ox-LDL

Maffeis C, et al. Nutr Metab Cardiovasc Dis 2011

POSTPRANDIAL PRO-ATEROGENIC PROFILE: change of oxidized lipoprotein concentration in obese children after two isocaloric,

isoproteic meals with a different fat and carbohydrate content

Fat/Carbohydrate

Fat/Carbohydrate

Time (h)0 5

Page 42: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Relation between increasing intakes of trans, saturated, unsaturated, monounsaturated, and polyunsaturated fatty acid (compared isocalorically

with carbohydrate) in relation to total mortality.

Data are based on 126,233 men and women followed for up to 32 years, with assessments every 4 years (Wang et al. JAMA 2016;176:1134-45). The strong inverse association with polyunsaturated fatty acids was primarily due to N-6 polyunsaturated fatty acids; associations with N-3 polyunsaturated fatty acids were weaker.

Ludwig DS, et al. Science 2018;362:764-70

Page 43: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Joint classification of whole- and refined-grain intake on visceral adipose tissue (VAT) volume

McKeown N M et al. Am J Clin Nutr 2010;92:1165-1171

Page 44: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis

U-shaped association between percentage of energy from carbohydrateand all-cause mortality in the ARIC and PURE cohort studies

46.3%

Seidelmann SB et al. Lancet Public Health 2018;3:e419-28

Page 45: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Mean values of cardiovascular risk score through the groups of adherence to a MedDiet (Low adherence vs. High adherence), cardiorespiratory fitness

(Low CRF vs. High CRF),and muscular fitness (Low MF vs. High CRF)

Bars represent adjusted means and 95% confidence intervals, for age, sex, pubertal stage and country, as confounders.

Optimal Adherence to a Mediterranean Diet May Not Overcome the Deleterious Effects of Low Physical Fitness on Cardiovascular Disease Risk

in Adolescents: A Cross-Sectional Pooled Analysis

Agostinis-Sobrinho C, et al. Nutrients 2018;10:815

Page 46: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Efficacy of a 12 Weeks Exercise Program withoutDiet in Reducing Obesity in Men

Ross R, et al. Ann Intern Med. 2OOO;133:92-1O3.

0 - 2 - 8- 4 - 6

Body weight (kg)

Waist circumference (cm)

Body fat (kg)

Subcutaneous abdominal fat (kg)

Visceral abdominal fat (kg)

- 10

Exercise: brisk walking/light jogging, 80% max HR, 700 kcal/day.

VO2max (L/min)

Page 47: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

2.00

0.80

0.40

1.60

1.20

Leastfit

Lowfit

Referentgroup

Moderatefit

Fit High fit

Age (yrs)

< 50

50-59

60-69

> 70

Ad

just

edm

ort

alit

yri

skac

cord

ing

to f

itn

ess

cate

gori

esAge-Specific Exercise Capacity Threshold

for Mortality Risk Assessment in Male Veterans

Kokkinos P, et al. Circulation 2014;130:653-8.

*adjusted for: age, blood pressure, race, site, beta-blockers, calcium channel blockers, ACE inhibitors angiotensin receptor blockers, Aspirin, diuretics, lipid-lowering agents, history of smoking, history of CVD, T2DM, muscle-wasting disease, alcohol/drug abuse, dyslipidemia,hypertension, and year of entry in the study,

P<0.001*

Threshold(METs)

8-9

7-8

6-7

5-6

Page 48: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Lee D, et al. J Am Coll Cardiol 2014;64:472-81

Leisure-Time Running Reduces All-Cause and CardiovascularMortality Risk In a 15-year follow-up

Page 49: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Lee D, et al. J Am Coll Cardiol 2014;64:472-81

Leisure-Time Running Reduces All-Cause and CardiovascularMortality Risk In a 15-year follow-up

Running, even 5 to 10 min/day and atslow speeds <6 miles/h, is associatedwith markedly reduced risks of death

from all causes and cardiovasculardisease

Page 50: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis

Barry VW, et al. Prog Cardiovasc Dis 2014;56:382-90

Page 51: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

WHO, 2015

Page 52: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Indicazioni operative

Allattamento al seno

Colazione

Pasti consumati in famiglia (vs Fast Food)

Alimentazione bilanciata in nutrienti (RDA)

Frutta e vegetali, Fibra

Densità energetica dei cibi e dei pasti

Porzioni

Bevande zuccherate

Video-esposizione

Attività fisica (>60 min/giorno di attività moderata/intensa

Page 53: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

PDTA Obesità Pediatrica

I livello: Pediatra di Famiglia / Medico di Medicina Generale

II livello: Equipe multidisciplinare

III livello: Centro Specializzato Obesità Pediatrica

Modello di rete: Hub & Spoke

Page 54: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic
Page 55: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Consensus Conference su Diagnosi, Trattamento e Prevenzione dell’Obesità del Bambino e dell’Adolescente

• Diagnosi

• Comorbilità

• Terapia

• Prevenzione

Page 56: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

fetal & perinatal programming

Cripps et al. Clin Sci 2005, modified

healthymother

optimalmaternalnutrition

goodplacentalfunction

othermaternal

abnormalitiesalcohol, smoking

Maternalundernutrition,

obesity,diabetes, …

poorplacentalfunction

inadequate fetalnutrition

obese adult

adequate fetalnutrition

optimalfetal

growth

low plane ofpost-natal nutrition

thin adult

Programming:

AppetiteGrowth

Hormonal milieuEnergy expend.

post-natalovernutrition

highbirth

weight

lowbirth

weight

PREGNANCY

LACTATION

Page 57: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

“… When parental and perinatal variables were

included as independent variables in a multiple logistic

regression model controlling for the effect of age,

parental body mass index and children's birth-weight

remained independently associated with childhood obesity. “

Maffeis C, et al. Int J Obes 1994;18:301-5.

parental and perinatal factors associated with childhood obesity in north-east Italy

Page 58: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Fattori di rischio di obesità

Peso alla nascita

Peso a termine (kg)4.52.5

Page 59: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Velocità di crescita primo anno

Lunghezza (cm)7545 6555

Peso (kg)

0

12

8

4

Page 60: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Prevention of Obesity in Toddlers (PROBIT):

a Randomised Clinical Trial of Responsive Feeding Promotion from Birth to 24 Months

Morandi A, Tommasi M, Soffiati F, Destro F, Grando F, Simonetti G, Bucolo C, Alberti E, Baraldi L, Chiriaco A, Ferrarese N, Frignani G, Pasqualini M, Rossi V, Siciliano C, Zuccolo AM, Matticchio G, Vettori V, Danieli D, Guarda L, Iuliano M, Raimo F, Sirpresi S, Trevisan E, Vinco S, Maffeis C.

Scaligera Local Health and Social Care Service, Verona (I)Polesana Local Health and Social Care Service, Rovigo (I) Dolomiti Local Health and Social Care Service, Belluno (I)Euganea Local Health and Social Care Service, Padua (I) Berica Local Health and Social Care Service, Vicenza (I)Pediatric Diabetes and Metabolic Disorders Unit, University of Verona, (I)

International Journal Obesity 2019 (in press)

Page 61: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Morandi A, et al. Int J Obesity 2019

Prevention of Obesity in Toddlers (PROBIT):

a Randomised Clinical Trial of Responsive Feeding Promotion from Birth to 24 Months

Page 62: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

informative sheet given to parents of newborns at the first well visit

Page 63: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

informative sheets given to parents of infants at the well visit of 3 months of age

Page 64: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Prevention of Obesity in Toddlers (PROBIT):

a Randomised Clinical Trial of Responsive Feeding Promotion from Birth to 24 Months

Morandi A, et al. Int J Obesity 2019

Page 65: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

comparisons between the two PROBIT arms from 3 to 12 months of age

Morandi A, et al. Int J Obesity 2019

Prevention of Obesity in Toddlers (PROBIT):

a Randomised Clinical Trial of Responsive Feeding Promotion from Birth to 24 Months

Page 66: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

15

10

5

0

P=010

comparisons between the two PROBIT arms at 2 years of age

Morandi A, et al. Int J Obesity 2019

InterventionGroup

(n=252)

ControlGroup

(n=216)

Prevalenceof obesity

(%)

Prevention of Obesity in Toddlers (PROBIT):

a Randomised Clinical Trial of Responsive Feeding Promotion from Birth to 24 Months

Page 67: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

Morandi A, et al. Int J Obesity (in press)

Conclusions

Prevention of Obesity in Toddlers (PROBIT):

a Randomised Clinical Trial of Responsive Feeding Promotion from Birth to 24 Months

The PROBIT trial was not effective in significantly decreasingthe general population prevalence of overweight/obesity attwo years of age.

However, it did demonstrate that an educational programme entirely based on the routine pediatric follow-up visits provided by a public healthcare system is wellaccepted by families and effective in increasing the adoption of protective feeding behaviours during the first year of life.

Page 68: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

conclusioni

L’obesità è la malattia metabolica più comune nel bambino come nell’adulto.

La prevenzione dell’obesità deve iniziare il prima possibile (vita fetale, primi 1000 giorni di vita) e proseguire per tutta l’età evolutiva.

La diagnosi di sovrappeso è già sufficiente per la prescrizione del trattamento.

Nutrizione e attività fisica sono gli strumenti principali della terapia.

La rete per l’obesità pediatrica, organizzata su tre livelli (PDTA), è il setting di cura ideale per un assistenza adeguata che vede nell’equipe multidisciplinare l’elemento irrinunciabile alla sua realizzazione.

Page 69: CLAUDIO MAFFEIS - Federazione Italiana Medici Pediatri · L F me a l H F me a l Time (min) TAG (mg/dl) p< 0.05 Postprandial triacylglycerol profile after two isocaloric, isoproteic

UOC PEDIATRIA INDIRIZZO DIABETOLOGICO E MALATTIE DEL METABOLISMO

UNIVERITA’ e AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA

GRAZIE